Clinical Trials Logo

Clinical Trial Summary

This study aims to determine the role of serum biomarkers and placental bloodflow in the comprehensive evaluation of the risk for spontaneous abortion


Clinical Trial Description

To study the added value (if any) of combining serum markers, immunologic factors, and ultrasound parameters in comprehensively evaluating the risk for spontaneous abortion. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04456660
Study type Observational
Source Orthogyn Medical Center, Bulgaria
Contact Petar N Ignatov, PhD
Phone 0035988896318
Email ignatov@orthogyn.com
Status Recruiting
Phase
Start date June 20, 2020
Completion date December 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT02657200 - Knowledge, Attitude and Practices of Flemish Midwifes Regarding Spontaneous Abortion N/A
Recruiting NCT03332706 - the Association Between Blood's and Urinary Heavy Metal Level in Pregnant Women and the Spontaneous Abortion N/A
Recruiting NCT04003064 - Heavy Metals' Influence on Early Pregnancy Through Oxidative Stress
Completed NCT01857310 - Folic Acid and Zinc Supplementation Trial (FAZST) N/A
Completed NCT00467363 - The Effects of Aspirin in Gestation and Reproduction N/A
Completed NCT00878098 - Study of DDT and Loss of Clinically-Recognized Pregnancies in South Africa
Recruiting NCT04705324 - Dilation and Curettage Versus Operative Hysteroscopy for Missed Abortion N/A
Completed NCT02012491 - Comparative Effectiveness of Pregnancy Failure Management Regimens Phase 3
Recruiting NCT05492708 - The Heartland Study
Completed NCT04017754 - Low Plasma Mannose Binding Lectin (p-MBL) Level is a Risk Factor for Recurrent Pregnancy Loss (RPL)
Active, not recruiting NCT04156126 - Measuring Immune Tolerance to Predict Miscarriage or Failed Embryo Transfer
Completed NCT02725710 - Gabapentin as an Adjunct to Perioperative Pain Management Regimens for Uterine Aspiration Phase 2
Recruiting NCT04182503 - Environmental Factors and Embryonic Development Project